Internal Medicine, Pulmonary Disease · Springfield, OH
NPI
1134166317
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2029 East High Street, Suite 101
Springfield, OH, 45505
Phone (937) 325-9450
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
2,205 services
Medicare patients, 2024
492
Average age 73
Drug cost, 2024
$1.5M
4,157 prescriptions
Company payments, 2025
$2,494
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Moin A Ranginwala was code 99213 (office e&m - established), 846 times for 341 patients. In total Moin A Ranginwala billed 2,205 services in 29 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 846 | 341 | $59.08 | $50K |
| 99232 Hospital E&M - Subsequent | Facility | 439 | 95 | $59.53 | $26K |
| 99222 Hospital E&M - Initial | Facility | 90 | 76 | $98.57 | $8,871 |
| 99233 Hospital E&M - Subsequent | Facility | 87 | 20 | $89.38 | $7,776 |
| 99406 Behavioral Health Services | Office | 86 | 44 | $13.77 | $1,184 |
| 99214 Office E&M - Established | Office | 83 | 60 | $85.39 | $7,088 |
| 99204 Office E&M - New | Office | 66 | 66 | $106.16 | $7,007 |
| Q2035 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | Office | 47 | 47 | $15.25 | $717 |
| G0008 Administration of influenza virus vaccine | Office | 46 | 46 | $29.44 | $1,354 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 46 | 43 | $25.56 | $1,176 |
| 94060 Pulmonary Function Testing | Facility | 36 | 36 | $7.35 | $265 |
| 94729 Pulmonary Function Testing | Facility | 36 | 36 | $6.49 | $234 |
| 94727 Pulmonary Function Testing | Facility | 35 | 35 | $8.48 | $297 |
| 95810 Sleep Study | Office | 32 | 31 | $85.42 | $2,733 |
| 94060 Pulmonary Function Testing | Office | 26 | 26 | $28.34 | $737 |
By year: 2022 $176K for 3,612 services; 2023 $158K for 2,961 services; 2024 $125K for 2,205 services.
Medicare prescription drug claims, 2024
In 2024, the drug Moin A Ranginwala prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 903 prescriptions and refills. In total Moin A Ranginwala wrote 4,157 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 903 | 1,149 | 260 | $26K |
| Montelukast Sodium Generic | 559 | 981 | 126 | $6,479 |
| Theophylline Er Theophylline Anhydrous | 257 | 386 | 40 | $12K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 249 | 308 | 46 | $193K |
| Azithromycin Generic | 219 | 219 | 118 | $1,020 |
| Methylprednisolone Generic | 194 | 194 | 101 | $1,324 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 174 | 223 | 46 | $138K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 172 | 252 | 40 | $112K |
| Spiriva Respimat Tiotropium Bromide | 134 | 165 | 36 | $84K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 128 | 151 | 27 | $70K |
| Ventolin Hfa Albuterol Sulfate | 96 | 126 | 35 | $7,094 |
| Ropinirole Hcl Generic | 79 | 163 | 19 | $1,276 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 73 | 111 | 18 | $10K |
| Fluticasone Propionate Generic | 69 | 110 | 24 | $844 |
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 67 | 93 | 18 | $38K |
Brand drugs: - claims; generic drugs: 2,171 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Moin A Ranginwala $2,494 ($2,494 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $721.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $721 |
| Genzyme Corporation SNY | 11 | $373 |
| Mallinckrodt Hospital Products Inc. | 3 | $262 |
| Amgen Inc. AMGN | 3 | $252 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $216 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $121 |
| Insmed, Inc. INSM | 4 | $93.63 |
| GlaxoSmithKline, LLC. GSK | 4 | $66.13 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $45.37 |
| Baxter Healthcare BAX | 2 | $44.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.